SectorPharmaceutical
Established Date21/08/2007
Listing Date08/10/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees14
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2500 Westchester Ave. Purchase
NY 10577
Business
IntroductionCognition Therapeutics, Inc., was incorporated under the laws of the State of Delaware on August 21, 2007. The Company is a clinical-stage biopharmaceutical company focused on the development of small molecule therapies for age-related degenerative diseases of the central nervous system and retina. Its lead drug candidate zervimesine is an oral therapy designed to protect neuronal synapses by targeting protein oligomers and has been evaluated in clinical trials in Alzheimer's disease, Lewy body dementia and map-like atrophy.
